Insider · CIK 0001844398
Jennifer Lynn Minai-Azary
Files at CNTX (Context Therapeutics Inc.). First filing Jun 10, 2025, latest Jun 10, 2025.
Jennifer Lynn Minai-Azary files SEC Form 4 as CFO at CNTX (Context Therapeutics Inc.). Since Jun 10, 2025, Jennifer Lynn Minai-Azary has reported 1 open-market buy worth $25k and 0 open-market sells worth $0, the latest filed on Jun 10, 2025.
A track record needs three past buys with six months of prices behind them; Jennifer Lynn Minai-Azary has 0, so none is measured yet.
The newest scored trade: bought $25k of CNTX on Jun 6, 2025, filed Jun 10, 2025, scored 52 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CNTX: Context Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | Context Therapeutics Inc. | $25k 40,010 shares | +100% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | CNTX Context Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Feb 23, 2026 |
| Jun 6, 2025 | CNTX Context Therapeutics Inc. | POpen-market purchase Common Stock | +40,010 | $0.64 | $25k | 80,010 | Jun 10, 2025 |
| Feb 13, 2025 | CNTX Context Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +371,800 | $0.00 | $0 | 371,800 | Feb 14, 2025 |
Questions about Jennifer Lynn Minai-Azary
Answered from the filings on this page, as of the latest one.
Is Jennifer Lynn Minai-Azary buying or selling?
Not in the last 12 months. Jennifer Lynn Minai-Azary's latest open-market trade on SEC Form 4 was bought $25k of CNTX on Jun 6, 2025.
How did Jennifer Lynn Minai-Azary's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jennifer Lynn Minai-Azary has 0.
Where does Jennifer Lynn Minai-Azary file Form 4?
Jennifer Lynn Minai-Azary has filed Form 4 at CNTX (Context Therapeutics Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.